EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Changes in Melanoma Cell Morphology Following Inhibition of Cell Invasion by Third-Generation mTOR Kinase Inhibitors

Dorota Ciołczyk-Wierzbicka iD, Martyna Sikorska-Duplicka, Marta Zarzycka iD, Grzegorz Zemanek iD, Karol Wierzbicki

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26167770 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Dorota Ciołczyk-Wierzbicka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Medical Genomics-OMICRON, Jagiellonian University Medical College, ul. Kopernika 7c, 31-034 Kraków, Poland. Hauptthemen laut MEDLINE: Melanoma, MTOR Inhibitors, TOR Serine-Threonine Kinases, Protein Kinase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education through Jagiellonian University Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma is one of the most invasive skin cancers with the highest mortality risk. The PI3K/AKT/mTOR signaling pathways are a key regulatory point related to growth factors and involved in the cell’s energy metabolism. They are responsible for cell life processes such as growth, proliferation, invasion, survival, apoptosis, autophagy, and angiogenesis. The studies undertaken concerned the effect of protein kinase inhibitors involved in the signaling pathways of AKT, MEK, and mTOR kinases on the expression of cytoskeletal and extracellular matrix proteins, invasion process, and activities of the matrix metalloproteinases (MMPs): MMP-2 and MMP-9 in melanoma cells. The study used mTOR kinase inhibitors: Everolimus and Torkinib; dual PI3K/mTOR inhibitors BEZ-235 and Omipalisib; and the mTORC1/2 inhibitor OSI-027. These compounds were used both as monotherapy and in combination with the MEK1/2 inhibitor AS-703026. mTOR kinase inhibitors, especially the third generation in combination with the MEK 1/2 kinase inhibitor AS-703026, significantly inhibited invasion and metalloproteinases (MMPs) activity in melanoma cell lines. The inhibition of the cell invasion process was accompanied by a significant change in the expression of proteins associated with EMT. The morphology of cells also changed significantly: their thickness, volume, roughness, convexity of shape, and irregularity, which may be a good diagnostic and prognostic factor for the response to treatment. Our studies to date on the effect of three generations of mTOR kinase inhibitors on the inhibition of the invasion process, the activation of apoptosis, and the reduction in cell proliferation suggest that they may be an important target for anticancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaMTOR InhibitorsTOR Serine-Threonine KinasesProtein Kinase InhibitorsSkin NeoplasmsHumansCell Line, TumorNeoplasm InvasivenessMatrix Metalloproteinase 2Cell ProliferationEverolimusSignal TransductionMatrix Metalloproteinase 9ImidazolesCell MovementApoptosis

Stichwörter der Autor:innen

cell invasioncell morphologymTOR protein kinase inhibitorsmelanoma

Substanzen

MTOR InhibitorsTOR Serine-Threonine KinasesMatrix Metalloproteinase 2EverolimusMTOR protein, humanMatrix Metalloproteinase 9ImidazolesProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Center for Medical Genomics-OMICRON, Jagiellonian University Medical College, ul. Kopernika 7c, 31-034 Kraków, Poland.
  • John Paul II Hospital, ul. Prądnicka 80, 31-202 Kraków, Poland.
  • Chair of Medical Biochemistry, Jagiellonian University Medical College, ul. Kopernika 7, 31-034 Kraków, Poland.
  • Department of Cardiovascular Surgery and Transplantology, Institute of Cardiology, Jagiellonian University Medical College, ul. Prądnicka 80, 31-202 Kraków, Poland.

ORCID-Profile: Dorota Ciołczyk-Wierzbicka, Marta Zarzycka, Grzegorz Zemanek

Förderung

  • Ministry of Science and Higher Education through Jagiellonian University Medical College

Zitieren

APA

Ciołczyk-Wierzbicka, D., Sikorska-Duplicka, M., Zarzycka, M., Zemanek, G., & Wierzbicki, K. (2025). Changes in Melanoma Cell Morphology Following Inhibition of Cell Invasion by Third-Generation mTOR Kinase Inhibitors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167770

Vancouver

Ciołczyk-Wierzbicka D, Sikorska-Duplicka M, Zarzycka M, Zemanek G, Wierzbicki K. Changes in Melanoma Cell Morphology Following Inhibition of Cell Invasion by Third-Generation mTOR Kinase Inhibitors. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167770

BibTeX
@article{CioczykWierzbicka2025,
  author = {Ciołczyk-Wierzbicka, Dorota and Sikorska-Duplicka, Martyna and Zarzycka, Marta and Zemanek, Grzegorz and Wierzbicki, Karol},
  title = {Changes in Melanoma Cell Morphology Following Inhibition of Cell Invasion by Third-Generation mTOR Kinase Inhibitors},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26167770}
}
Kostenlos starten →